CorMedix (CRMD) Inventory Average (2016 - 2025)
CorMedix's (CRMD) quarterly Inventory Average came in at $19.5 million in Q4 2025, up 1749.93% year-on-year from $1.1 million in Q4 2024, and up 228.03% quarter-over-quarter from $5.9 million in Q3 2025.
CorMedix (CRMD) Inventory Average (2016 - 2025) Analysis & Trends
CorMedix has disclosed Inventory Average across 9 years of filings, most recently posting $19.5 million for Q4 2025.
- Inventory Average for Q4 2025 came in at $19.5 million, up 1749.93% year-over-year; the trailing twelve-month figure through Dec 2025 was $19.5 million (up 1749.93% YoY), and the FY2025 annual result was $15.4 million, up 877.79% from the prior year.
- Inventory Average came in at $19.5 million for Q4 2025 at CorMedix, up from $5.9 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $19.5 million in Q4 2025 to a low of $994.5 in Q3 2022.
- The 4-year median for Inventory Average is $1.1 million (2024), against an average of $2.6 million.
- Across the five-year window, Inventory Average sank 98.36% in 2022 and soared 1749.93% in 2025, its largest moves.
- CorMedix's Inventory Average stood at $25963.0 in 2021, then tumbled by 96.17% to $994.5 in 2022, then surged by 105781.7% to $1.1 million in 2024, then jumped by 1749.93% to $19.5 million in 2025.
- The last three Inventory Average figures came in at $19.5 million (Q4 2025), $5.9 million (Q3 2025), and $2.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | 19.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.48 Mn |
| Sep 30, 2025 | 5.94 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 2.54 Mn |
| Jun 30, 2024 | 3.17 Mn |
| Mar 31, 2024 | 2.21 Mn |
| Sep 30, 2022 | 994.50 |
| Jun 30, 2022 | 2,167.00 |
| Mar 31, 2022 | 2,811.00 |
| Dec 31, 2021 | 25,963.00 |
| Sep 30, 2021 | 60,822.50 |
| Jun 30, 2021 | 78,899.00 |
| Mar 31, 2021 | 114,317.50 |
| Dec 31, 2020 | 172,135.00 |
| Sep 30, 2020 | 239,270.50 |
| Jun 30, 2020 | 286,371.50 |
| Mar 31, 2020 | 316,686.50 |
| Dec 31, 2019 | 359,765.00 |